Who we are
Our vision is to broaden the access to therapeutic solutions sustainably, driven by science, and through collaboration with physicians, researchers, companies, health authorities and patients.
SUSTAINABLE
We consider creating an impact for patients the most important task at hand. Our goal is to ensure sustainable access for patients to the right treatment promptly and for years to come.
SCIENCE DRIVEN
We trust in science as a driver for medical innovations. From the discovery to the generation of evidence, science is what brings medical innovations to patients.
COLLABORATIVE
We believe that bringing medical innovations to patients is not only a collaborative effort within internal teams, it is also about openly engaging around the needs of external stakeholders.
AXTALIS [æks:tɑ:liz]
The name originates from combining the words "Access" and "Talisman". Our logo was envisioned to resemble a talisman and its good fortune.
Access
[noun]
The means or opportunity to approach or enter a place.
Talisman
[noun]
An object, typically an inscribed ring or stone, that is thought to have magic powers and to bring good luck.
AxTalis is a consulting company that focuses on supporting pharma companies in Regulatory Affairs, Market Access, and Medical Affairs across the BeNeLux and Nordics regions.
As the complexity of the healthcare environment increases, Regulatory Affairs, Market Access, and Medical Affairs functions are working closer together than ever to ensure sustained availability of therapeutic offerings.
AxTalis mirrors a pharmaceutical affairs department, offering a dedicated cross-functional team as a service or individual plug-and-play components.
Our strength lies in our people. The AxTalis crew is a blend of passionate, committed people with different backgrounds and experiences in the pharmaceutical industry. Thanks to its multicoloured traits, our team works closely with our clients to develop and implement value-adding projects with a broad view and understanding.